Sales rise 16.33% to Rs 681.85 crore
Net profit of Marksans Pharma rose 25.61% to Rs 104.56 crore in the quarter ended December 2024 as against Rs 83.24 crore during the previous quarter ended December 2023. Sales rose 16.33% to Rs 681.85 crore in the quarter ended December 2024 as against Rs 586.13 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales681.85586.13 16 OPM %20.3522.69 -PBDT163.95134.66 22 PBT143.26112.66 27 NP104.5683.24 26Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
